Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 5, 2023 $20.77 -1.28% $21.02 V 98.81% 2
Sep 5, 2023 Bullish $21.02 X 0
Aug 22, 2023 $17.11 +1.97% $17.23 V 99.31% 4
Aug 22, 2023 $16.99 +1.23% $17.23 V 98.59% 2
Aug 22, 2023 Bearish $17.23 X 0
Jun 28, 2023 $24.45 +1.88% $23.77 X 97.13% 0
Jun 28, 2023 $24.28 +1.18% $23.77 X 97.84% 0
Jun 28, 2023 Bearish $23.77 X 1
Jun 14, 2023 $25.08 -1.99% $25.33 V 99.01% 2
Jun 14, 2023 $25.27 -1.25% $25.33 V 99.77% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE